{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:43:06Z","timestamp":1790678586408,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish Foundation of Strategic Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Using high-sensitivity cardiac troponin (hs-cTn) assays with sex-specific 99th percentiles may improve management of patients with suspected acute myocardial infarction (AMI). We investigated the impact of transitioning from a conventional troponin I assay to a high-sensitivity assay with sex-specific\u00a0thresholds, in patients with suspected acute coronary syndrome admitted to Swedish coronary care units. Based on data from SWEDEHEART registry (females, n\u2009=\u20094,819\/males, n\u2009=\u20097,670), we compared periods before and after implementation of hs-cTnI assay (Abbott) using sex-specific 99th percentiles. We investigated differences on discharge diagnosis, in-hospital examinations, treatments, and clinical outcome. Upon implementation of the hs-cTnI assay, proportion of patients with troponin levels above diagnostic AMI threshold increased in women and men by 24.3% versus 14.8%, respectively. Similarly, incidence of AMI increased by 11.5% and 9.8%. Diagnostic interventions and treatments increased regardless of sex. However, these associations did not persist following multivariable adjustment, probably due to the effect of temporal management trends during the observation period. Overall, no risk reduction on major adverse cardiovascular events was observed (HR: 0.91 [95% CI 0.80\u20131.03], <jats:italic>P<\/jats:italic>\u2009=\u20090.126). The implementation of hs-cTnI assay together with sex-specific 99th percentiles was associated with an increase in incidence of AMI regardless of sex, but had no major impact on clinical management and prognosis.<\/jats:p>","DOI":"10.1038\/s41598-020-72204-2","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T21:28:45Z","timestamp":1600378125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Sex-specific effects of implementing a high-sensitivity troponin I assay in patients with suspected acute coronary syndrome: results from SWEDEHEART registry"],"prefix":"10.1038","volume":"10","author":[{"given":"Dorien M.","family":"Kimenai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Jernberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Bekers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J. R.","family":"Meex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai M.","family":"Eggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"key":"72204_CR1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/eurheartj\/eht530","volume":"35","author":"C Mueller","year":"2014","unstructured":"Mueller, C. Biomarkers and acute coronary syndromes: An update. Eur. Heart J. 35, 552\u2013556. https:\/\/doi.org\/10.1093\/eurheartj\/eht530 (2014).","journal-title":"Eur. Heart J."},{"key":"72204_CR2","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1056\/NEJMoa0900428","volume":"361","author":"T Reichlin","year":"2009","unstructured":"Reichlin, T. et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N. Engl. J. Med. 361, 858\u2013867. https:\/\/doi.org\/10.1056\/NEJMoa0900428 (2009).","journal-title":"N. Engl. J. Med."},{"key":"72204_CR3","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1056\/NEJMoa0903515","volume":"361","author":"T Keller","year":"2009","unstructured":"Keller, T. et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N. Engl. J. Med. 361, 868\u2013877. https:\/\/doi.org\/10.1056\/NEJMoa0903515 (2009).","journal-title":"N. Engl. J. Med."},{"key":"72204_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi, M. et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 37, 267\u2013315. https:\/\/doi.org\/10.1093\/eurheartj\/ehv320 (2016).","journal-title":"Eur. Heart J."},{"key":"72204_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy462","author":"K Thygesen","year":"2018","unstructured":"Thygesen, K. et al. Fourth universal definition of myocardial infarction (2018). Eur. Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehy462 (2018).","journal-title":"Eur. Heart J."},{"key":"72204_CR6","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/s0735-1097(00)00804-4","volume":"36","author":"JS Alpert","year":"2000","unstructured":"Alpert, J. S., Thygesen, K., Antman, E. & Bassand, J. P. Myocardial infarction redefined\u2014A consensus document of The Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 36, 959\u2013969. https:\/\/doi.org\/10.1016\/s0735-1097(00)00804-4 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"72204_CR7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)31923-8","volume":"392","author":"ASV Shah","year":"2018","unstructured":"Shah, A. S. V. et al. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: A stepped-wedge, cluster-randomised controlled trial. Lancet 392, 919\u2013928. https:\/\/doi.org\/10.1016\/S0140-6736(18)31923-8 (2018).","journal-title":"Lancet"},{"key":"72204_CR8","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1093\/eurheartj\/ehw029","volume":"37","author":"KM Eggers","year":"2016","unstructured":"Eggers, K. M., Lindahl, B., Melki, D. & Jernberg, T. Consequences of implementing a cardiac troponin assay with improved sensitivity at Swedish coronary care units: An analysis from the SWEDEHEART registry. Eur. Heart J. 37, 2417\u20132424. https:\/\/doi.org\/10.1093\/eurheartj\/ehw029 (2016).","journal-title":"Eur. Heart J."},{"key":"72204_CR9","doi-asserted-by":"publisher","first-page":"g7873","DOI":"10.1136\/bmj.g7873","volume":"350","author":"AS Shah","year":"2015","unstructured":"Shah, A. S. et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: Prospective cohort study. BMJ 350, g7873. https:\/\/doi.org\/10.1136\/bmj.g7873 (2015).","journal-title":"BMJ"},{"key":"72204_CR10","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin, E. J. et al. Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation 135, e146\u2013e603. https:\/\/doi.org\/10.1161\/CIR.0000000000000485 (2017).","journal-title":"Circulation"},{"key":"72204_CR11","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.jacc.2019.07.082","volume":"74","author":"KK Lee","year":"2019","unstructured":"Lee, K. K. et al. Sex-specific thresholds of high-sensitivity troponin in patients with suspected acute coronary syndrome. J. Am. Coll. Cardiol. 74, 2032\u20132043. https:\/\/doi.org\/10.1016\/j.jacc.2019.07.082 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"72204_CR12","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1373\/clinchem.2017.271684","volume":"63","author":"KM Eggers","year":"2017","unstructured":"Eggers, K. M. & Lindahl, B. Impact of sex on cardiac troponin concentrations\u2014A critical appraisal. Clin. Chem. 63, 1457\u20131464. https:\/\/doi.org\/10.1373\/clinchem.2017.271684 (2017).","journal-title":"Clin. Chem."},{"key":"72204_CR13","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1373\/clinchem.2018.286781","volume":"64","author":"DM Kimenai","year":"2018","unstructured":"Kimenai, D. M. et al. Sex-specific versus overall clinical decision limits for cardiac troponin I and T for the diagnosis of acute myocardial infarction: A systematic review. Clin. Chem. 64, 1034\u20131043. https:\/\/doi.org\/10.1373\/clinchem.2018.286781 (2018).","journal-title":"Clin. Chem."},{"key":"72204_CR14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1373\/clinchem.2015.252569","volume":"62","author":"C Trambas","year":"2016","unstructured":"Trambas, C. et al. Impact of high-sensitivity troponin I testing with sex-specific cutoffs on the diagnosis of acute myocardial infarction. Clin. Chem. 62, 831\u2013838. https:\/\/doi.org\/10.1373\/clinchem.2015.252569 (2016).","journal-title":"Clin. Chem."},{"key":"72204_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5694\/mja13.00275","volume":"202","author":"L Cullen","year":"2015","unstructured":"Cullen, L. et al. Availability of highly sensitive troponin assays and acute coronary syndrome care: Insights from the SNAPSHOT registry. Med. J. Aust. 202, 36\u201339. https:\/\/doi.org\/10.5694\/mja13.00275 (2015).","journal-title":"Med. J. Aust."},{"key":"72204_CR16","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/jama.2011.338","volume":"305","author":"NL Mills","year":"2011","unstructured":"Mills, N. L. et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 305, 1210\u20131216. https:\/\/doi.org\/10.1001\/jama.2011.338 (2011).","journal-title":"JAMA"},{"key":"72204_CR17","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/heartjnl-2013-305440","volume":"100","author":"J Sanchis","year":"2014","unstructured":"Sanchis, J. et al. High-sensitivity versus conventional troponin for management and prognosis assessment of patients with acute chest pain. Heart 100, 1591\u20131596. https:\/\/doi.org\/10.1136\/heartjnl-2013-305440 (2014).","journal-title":"Heart"},{"key":"72204_CR18","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.jcin.2018.03.027","volume":"11","author":"KM Eggers","year":"2018","unstructured":"Eggers, K. M., Jernberg, T., Lindhagen, L. & Lindahl, B. High-sensitivity cardiac troponin T levels identify patients with non-ST-segment elevation acute coronary syndrome who benefit from invasive assessment. JACC Cardiovasc. Interv. 11, 1665\u20131667. https:\/\/doi.org\/10.1016\/j.jcin.2018.03.027 (2018).","journal-title":"JACC Cardiovasc. Interv."},{"key":"72204_CR19","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1093\/eurheartj\/ehy554","volume":"39","author":"K Szummer","year":"2018","unstructured":"Szummer, K. et al. Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: Experiences from SWEDEHEART registry 1995 to 2014. Eur. Heart J. 39, 3766\u20133776. https:\/\/doi.org\/10.1093\/eurheartj\/ehy554 (2018).","journal-title":"Eur. Heart J."},{"key":"72204_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-315667","author":"G Mnatzaganian","year":"2019","unstructured":"Mnatzaganian, G. et al. Sex disparities in the assessment and outcomes of chest pain presentations in emergency departments. Heart https:\/\/doi.org\/10.1136\/heartjnl-2019-315667 (2019).","journal-title":"Heart"},{"key":"72204_CR21","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elam","year":"2007","unstructured":"von Elam, E. et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement. Lancet 370, 1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X (2007).","journal-title":"Lancet"},{"key":"72204_CR22","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/ije\/dyw341","volume":"45","author":"J Textor","year":"2016","unstructured":"Textor, J., van der Zander, B., Gilthorpe, M. S., Liskiewicz, M. & Ellison, G. T. Robust causal inference using directed acyclic graphs: The R package \u2018dagitty\u2019. Int. J. Epidemiol. 45, 1887\u20131894. https:\/\/doi.org\/10.1093\/ije\/dyw341 (2016).","journal-title":"Int. J. Epidemiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72204-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72204-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72204-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:41:15Z","timestamp":1670355675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72204-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72204"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72204-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SJRM received research funding and lecture fees from Abbott Laboratories and Roche Diagnostics. KME has received honoraria from AstraZeneca, and has acted as consultant for Siemens Healthineers. DMK, BL, TJ, OB declared no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15227"}}